Avoiding an impairment of factor VIII:C by using hydroxyethyl starch with a low in vivo molecular weight

Anesth Analg. 1997 Jun;84(6):1391. doi: 10.1097/00000539-199706000-00047.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Deamino Arginine Vasopressin / pharmacology
  • Drug Interactions
  • Factor VIII / drug effects*
  • Factor VIII / metabolism
  • Humans
  • Hydroxyethyl Starch Derivatives / pharmacology*
  • Molecular Weight

Substances

  • Hydroxyethyl Starch Derivatives
  • Factor VIII
  • Deamino Arginine Vasopressin